Fabtech Technologies IPO

Incorporated in 2018, Fabtech Technologies Ltd is a biopharma engineering company. The company designs and delivers turnkey projects, including cleanroom facilities, modular systems, and customized engineering solutions. It provides end-to-end services such as design, engineering, manufacturing, installation, and project management. With expertise in cleanroom technology, HVAC systems, and process equipment, Fabtech serves global clients, ensuring compliance with international regulatory standards. Services: Start-to-Finish: The company helps people in bio-pharma manufacturing life cycle from setting direction right through to taking your products to market. Clean Water Solutions: The company offer a comprehensive range of equipment for purified water and pure steam generation and distribution as well as water for injections with flow rates ranging from 500 LPH to 50,000 LPH. Clean Air Solutions: The company supported life sciences, food and beverage, IT, semiconductor, and aeronautics industries with innovative solutions for clean air applications that drive their growth and progress. As of July 31, 2025, the company had 185 permanent employees. Competitive Strengths: A key turnkey engineering solution provider offering integrated engineering solutions with comprehensive service offerings. In-house software technology capabilities Diversified order book across geographies, clients, and business verticals. Project execution across diverse and challenging geographies Efficient lead funnelling leading to higher mandate conversion Track record of executing projects across all dosage forms Experienced Leadership Team with Fabtech Group parentage

Funding working capital requirements of the Company Pursuing inorganic growth initiatives through acquisitions General Corporate Purposes